Recent studies have suggested that metalloproteinases (MMP) might be involv
ed in the pathogenesis of cerebral aneurysm formation and rupture and that
elevated serum levels of MMP may effectively be considered as possible mark
ers of cerebrovascular malformations The present study was planned in order
to verify if serum levels of MMPs may be the mirror of the MMP activity in
the wall of intracranial aneurysms, reflecting the predisposition to aneur
ysm development and/or rupture. A series of 84 patients operated for intrac
ranial cerebrovascular lesions (63 aneurysms and 21 artero-venous malformat
ions (AVM)) and 20 controls entered the study. Among the 63 cases of intrac
ranial aneurysms, nine were discovered before rupture, while 54 patients we
re included after subarachnoid hemorrhage (SAH). Using radioimmunoassay, pl
asma elastase levels were measured in all cases, while in 25 cases, when an
eurysmectomy was possible, the activity of elastase and collagenase were me
asured in aneurysm samples. Mean plasma elastase level in patients bearing
both an intracranial aneurysm or an intracranial AVM was significantly high
er than in controls, while there was no significant difference between plas
matic level of elastase in patients with aneurysms when compared with patie
nts bearing an intracranial AVM; there was no significant difference betwee
n mean elastase level in patients who suffered SAH and patients bearing an
intracranial unruptured aneurysm. The activity of elastase and collagenase
measured in the aneurysm wall were significantly higher in cases of rupture
d than in unruptured aneurysms. The present results show that plasmatic lev
el of elastase does not reflect the activity of MMP as measured in the aneu
rysm wall and that the patterns of MMP activities measured in the aneurysm
wall differ considerably at different stages of SAH. This suggests that loc
al rather than systemic changes in metalloproteases activity might be invol
ved in cerebral aneurysm formation and rupture.